Followers | 3818 |
Posts | 240339 |
Boards Moderated | 0 |
Alias Born | 07/30/2007 |
Wednesday, May 04, 2016 9:04:58 PM
DD by stervc. Pease read the entire link below.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=122333781&txt2find=bssp
The recent news below states that the new BSSP/Canteck Pharma, Inc. has initial deployment for sales of the specific Irreversible Pepsin Fraction (IPF) for Cancer indication product and treatment programs to Mexico are now in process with four (4) hospitals positioned and in process of licensing requirements which have been submitted. Canteck is positioned to oversee the development, manufacturing and commercialization processes for our lead product to be the Irreversible Pepsin Fraction (IPF) specific to the Cancer indication, with options for other indications:
http://finance.yahoo.com/news/reve-acquires-exclusive-license-cantecks-133000687.html
Significant BSSP/Canteck Pharma, Inc. Slideshow
http://www.cantechpharma.com/cancer-treatment/
http://www.cantechpharma.com/wp-content/uploads/2016/02/Cantech-Pharma-Fund-Immun-2015.pdf
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM